EdiGene (GuangZhou) Inc.
3 clinical trials · Sponsor
◉ Watch EdiGene (GuangZhou) Inc.
| Record | Firm | Date |
|---|---|---|
| A Study to Evaluate the Safety and Efficacy of ET-01 Transplantation in Subjects with Transfusion Dependent Β-Thalassaemia. (NCT05752123) | EdiGene (GuangZhou) Inc. | 2023-02-18 |
| A Safety and Efficacy Study Evaluating ET-01 in Subjects with Transfusion Dependent Β-Thalassaemia (NCT04925206) | EdiGene (GuangZhou) Inc. | 2021-08-17 |
| A Study of ET-02 in Patients With Relapsed or Refractory B-cell Malignancy(NHL/ALL) (NCT04933825) | EdiGene (GuangZhou) Inc. | 2021-07-20 |
Track EdiGene (GuangZhou) Inc. automatically
Every clearance here is in the API, with alerts when new ones post.